HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Pang, I.-H. Articles by Morrison, J. C. Search for Related Content PubMed PubMed Citation Articles by Pang, I.-H. Articles by Morrison, J. C.

Evaluation of Inducible Nitric Oxide Synthase in Glaucomatous Optic Neuropathy and Pressure-Induced Optic Nerve Damage

¹From Alcon Research, Ltd., Fort Worth, Texas; and the ²Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon.

PURPOSE. To determine whether inducible nitric oxide synthase (NOS-2) is involved in glaucomatous optic neuropathy.

METHODS. Chronic elevation of rat intraocular pressure (IOP) leading to optic nerve damage was induced by episcleral injection of hypertonic saline, which caused sclerosis and blockade of aqueous humor outflow pathways. Expression of NOS-2 in the retina and optic nerve head (ONH) was evaluated by immunohistochemistry, gene array analysis, and quantitative PCR (Q-PCR). Immunohistochemistry was also used to assess the NOS-2 level in the ONH from primary open-angle glaucoma (POAG) and nonglaucomatous human eyes. Finally, an NOS-2 inhibitor, aminoguanidine, administered orally in the drinking water, was tested for its effect on optic nerve injury in rats with ocular hypertension.

RESULTS. Chronically elevated IOP in the rat produced optic nerve damage that correlated with pressure change (r² = 0.77), but did not increase NOS-2 immunoreactivity in the optic nerve, ONH, or ganglion cell layer. Retinal and ONH NOS-2 mRNA levels did not correlate with either IOP level or severity of optic nerve injury. Similarly, there was no difference in NOS-2 immunoreactivity in the optic nerve or ONH between POAG and nonglaucomatous eyes. Furthermore, aminoguanidine treatment did not affect the development of pressure-induced optic neuropathy in the rat.

CONCLUSIONS. As demonstrated by several independent methods, glaucomatous optic neuropathy was not associated with a significant change in the expression of NOS-2 in the retina, ONH, or optic nerve.

This article has been cited by other articles:

				J. C. Morrison, L. Jia, W. Cepurna, Y. Guo, and E. Johnson Reliability and Sensitivity of the TonoLab Rebound Tonometer in Awake Brown Norway Rats Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2802 - 2808. [Abstract] [Full Text] [PDF]

				Z. Shi, M. Rudzinski, K. Meerovitch, F. Lebrun-Julien, E. Birman, A. Di Polo, and H. U. Saragovi {alpha}2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma J. Biol. Chem., October 24, 2008; 283(43): 29156 - 29165. [Abstract] [Full Text] [PDF]

				J. Du, T. Tran, C. Fu, and D. W. Sretavan Upregulation of EphB2 and ephrin-B2 at the Optic Nerve Head of DBA/2J Glaucomatous Mice Coincides with Axon Loss Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5567 - 5581. [Abstract] [Full Text] [PDF]

				E. C. Johnson, L. Jia, W. O. Cepurna, T. A. Doser, and J. C. Morrison Global Changes in Optic Nerve Head Gene Expression after Exposure to Elevated Intraocular Pressure in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3161 - 3177. [Abstract] [Full Text] [PDF]

				N. Belforte, M. C. Moreno, C. Cymeryng, M. Bordone, M. I. Keller Sarmiento, and R. E. Rosenstein Effect of Ocular Hypertension on Retinal Nitridergic Pathway Activity Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2127 - 2133. [Abstract] [Full Text] [PDF]